Effects of strength training on body composition, physical functioning, and quality of life in prostate cancer patients during androgen deprivation therapy

References

• Bolla M, Van Tienhoven G, Warde P, Dubois JB, Mirimanoff RO, Storme G, et al. External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study. Lancet Oncol 2010;11:1066–73.
   PubMed Web of Science ®Google Scholar
• Boxer RS, Kenny AM, Taxel P. The effect of 6 months of androgen deprivation therapy on muscle and fat mass in men with prostate cancer. J Am Geriatr Soc 2005;53:S71–2.
   Google Scholar
• van Londen GJ, Levy ME, Perera S, Nelson JB, Greenspan SL. Body composition changes during androgen deprivation therapy for prostate cancer: A 2-year prospective study. Crit Rev Oncol Hematol 2008;68:172–7.
   PubMed Web of Science ®Google Scholar
• Haseen F, Murray LJ, Cardwell CR, O’Sullivan JM, Cantwell MM. The effect of androgen deprivation therapy on body composition in men with prostate cancer: Systematic review and meta-analysis. J Cancer Survivor Res Pract 2010;4:128–39.
   PubMed Web of Science ®Google Scholar
• Tsang DS, Alibhai SM. Bone health care for patients with prostate cancer receiving androgen deprivation therapy. Hosp Pract 2014;42:89–102.
   Google Scholar
• Gardner JR, Livingston PM, Fraser SF. Effects of exercise on treatment-related adverse effects for patients with prostate cancer receiving androgen-deprivation therapy: A systematic review. J Clin Oncol 2014;32:335–46.
   PubMed Web of Science ®Google Scholar
• Galvão DA, Nosaka K, Taaffe DR, Spry N, Kristjanson LJ, McGuigan MR, et al. Resistance training and reduction of treatment side effects in prostate cancer patients. Med Sci Sports Exerc 2006;38:2045–52.
   PubMed Web of Science ®Google Scholar
• Galvão DA, Taaffe DR, Spry N, Joseph D, Newton RU. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: A randomized controlled trial. J Clin Oncol 2010;28: 340–7.
   PubMed Web of Science ®Google Scholar
• Segal RJ, Reid RD, Courneya KS, Malone SC, Parliament MB, Scott CG, et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 2003;21:1653–9.
   PubMed Web of Science ®Google Scholar
• Winters-Stone KM, Beer TM. Review of exercise studies in prostate cancer survivors receiving androgen deprivation therapy calls for an aggressive research agenda to generate high-quality evidence and guidance for exercise as standard of care. J Clin Oncol 2014;32:2518–9.
   PubMed Web of Science ®Google Scholar
• Kadi F, Bonnerud P, Eriksson A, Thornell LE. The expression of androgen receptors in human neck and limb muscles: Effects of training and self-administration of androgenic- anabolic steroids. Histochem Cell Biol 2000;113:25–9.
   PubMed Web of Science ®Google Scholar
• Thorsen L, Nilsen TS, Raastad T, Courneya KS, Skovlund E, Fossa SD. A randomized controlled trial on the effectiveness of strength training on clinical and muscle cellular outcomes in patients with prostate cancer during androgen deprivation therapy: Rationale and design. BMC Cancer 2012;12:123.
   PubMed Web of Science ®Google Scholar
• D’Amico AV, Moul J, Carroll PR, Sun L, Lubeck D, Chen MH. Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era. J Clin Oncol 2003;21:2163–72.
   PubMed Web of Science ®Google Scholar
• Simmonds MJ. Physical function in patients with cancer: Psychometric characteristics and clinical usefulness of a physical performance test battery. J Pain Symptom Manage 2002; 24:404–14.
   PubMed Web of Science ®Google Scholar
• Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality- of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365–76.
   PubMed Web of Science ®Google Scholar
• Kvorning T, Andersen M, Brixen K, Madsen K. Suppression of endogenous testosterone production attenuates the response to strength training: A randomized, placebo- controlled, and blinded intervention study. Am J Physiol Endocrinol Metab 2006;291:E1325–32.
   PubMed Web of Science ®Google Scholar
• Cormie P, Galvao DA, Spry N, Joseph D, Chee R, Taaffe DR, et al. Can supervised exercise prevent treatment toxicity in prostate cancer patients initiating androgen deprivation therapy: A randomised controlled trial. Br J Urol Int 2015; 115:256–66.
   Google Scholar
• Hanson ED, Sheaff AK, Sood S, Ma L, Francis JD, Goldberg AP, et al. Strength training induces muscle hypertrophy and functional gains in black prostate cancer patients despite androgen deprivation therapy. J Gerontol A Biol Sci Med Sci 2013;68:490–8.
   PubMed Web of Science ®Google Scholar
• Trost LW, Serefoglu E, Gokce A, Linder BJ, Sartor AO, Hellstrom WJ. Androgen deprivation therapy impact on quality of life and cardiovascular health, monitoring therapeutic replacement. J Sex Med 2013;10(Suppl 1):84–101.
   PubMed Web of Science ®Google Scholar
• Gomez-Cabello A, Ara I, Gonzalez-Aguero A, Casajus JA, Vicente-Rodriguez G. Effects of training on bone mass in older adults: A systematic review. Sports Med 2012;42: 301–25.
   PubMed Web of Science ®Google Scholar
• Winters-Stone KM, Dobek JC, Bennett JA, Maddalozzo GF, Ryan CW, Beer TM. Skeletal response to resistance and impact training in prostate cancer survivors. Med Sci Sports Exerc 2014;46:1482–8.
   PubMed Web of Science ®Google Scholar
• Dobek J, Winters-Stone KM, Bennett JA, Nail L. Musculoskeletal changes after 1 year of exercise in older breast cancer survivors. J Cancer Survivor Res Pract 2014; 8:304–11.
   PubMed Web of Science ®Google Scholar
• Segal RJ, Reid RD, Courneya KS, Sigal RJ, Kenny GP, Prud’Homme DG, et al. Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. J Clin Oncol 2009;27:344–51.
   PubMed Web of Science ®Google Scholar
• Bolla M, de Reijke TM, Van Tienhoven G, Van den Bergh AC, Oddens J, Poortmans PM, et al. Duration of androgen suppression in the treatment of prostate cancer. N Engl J Med 2009;360:2516–27.
   PubMed Web of Science ®Google Scholar
• Kalter J, Buffart LM, Korstjens I, van Weert E, Brug J, Verdonck-de Leeuw IM, et al. Moderators of the effects of group-based physical exercise on cancer survivors’ quality of life. Support Care Cancer Epub 2015 Feb 14.
   Google Scholar